Physician profile
Michael S Kipper
NPI 1639107964
$40,647.03
in general payments reported to CMS, 2019-2025
19 companies · $91.72 in 2025
The $91.72 reported for 2025 was less than what a typical Nuclear Radiology provider received nationally (typical 2025 total: $145).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $3,204 · 2021: $2,520 · 2022: $6,013 · 2023: $634 · 2024: $8,925 · 2025: $91.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,150 · Travel and Lodging: $2,160 · Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,150.00 |
| Travel and Lodging | $2,160.08 |
| Food and Beverage | $341.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $18,607.90 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $15,527.06 | 2022-2024 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $5,004.02 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $449.90 | 2019-2020 | |
| Astellas Pharma US INC | $291.55 | 2019-2020 | |
| Amgen INC. | $141.72 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $128.43 | 2019-2020 | |
| Janssen Biotech, INC. | $113.72 | 2019 | |
| Pfizer INC. | $59.98 | 2020 | |
| Antares Pharma, INC. | $59.55 | 2020 | |
| Voximetry, INC. | $56.49 | 2025 | |
| Novartis Pharmaceuticals Corporation | $55.34 | 2021-2025 | |
| Ge Healthcare | $26.51 | 2024 | |
| Merck Sharp & Dohme LLC | $24.60 | 2020 | |
| Bard Access Systems, INC. | $24.14 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clovis Oncology, INC. | $20.90 | 2020 | |
| Abbvie INC. | $19.25 | 2019 | |
| Foundation Medicine, INC. | $18.46 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $17.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kipper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.